Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: A cross-sectional case-control study

References

• Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988; 27: 142–9
   PubMedGoogle Scholar
• Lonardo A, Bellini M, Tartoni P, Tondelli E. The bright liver syndrome: prevalence and determinants of a “bright” liver echo pattern. Ital J Gastroenterol Hepatol 1997; 29: 351–6
   PubMed Web of Science ®Google Scholar
• Ballentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in northern Italy. Ann Intern Med 2000; 132: 112–7
   PubMedGoogle Scholar
• Hilden M, Christoffersen P, Juhl E, Dalgaard JB. Liver histology in a “normal” population: examinations of 503 consecutive fatal traffic casualties. Scand J Gastroenterol 1977; 12: 593–7
   PubMed Web of Science ®Google Scholar
• Friis-Liby I, Aldenborg F, Jerlstad P, Rundstrom K, Bjornsson E. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease. Scand J Gastroenterol 2004; 39: 864–9
   PubMed Web of Science ®Google Scholar
• Foster KJ, Dewbury KC, Griffith AH, Wright R. The accuracy of ultrasound in the detection of fatty infiltration of the liver. Br J Radiol 1980; 53: 440–2
   PubMedGoogle Scholar
• Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26–31
   PubMed Web of Science ®Google Scholar
• Lee JY, Yoo KH, Hahn SH. HFE gene mutation, C282Y causing hereditary hemochromatosis in Caucasians is extremely rare in the Korean population. J Korean Med Sci 2000; 15: 179–82
   PubMedGoogle Scholar
• Hahn SH, Lee SY, Jang YJ, Kim SN, Shin HC, Park SY, et al. Pilot study of mass screening for Wilson disease in Korea. Mol Genet Metab 2002; 76: 133–6
   PubMed Web of Science ®Google Scholar
• World Health Organization, Western Pacific Region, International Association for the Study of Obesity. The Asia-Pacific perspective: redefining obesity and its treatment. Sidney: Health Communications Australia Pty Ltd; 2000.
   Google Scholar
• Bioelectrical impedance analysis in body composition measurement. NIH Technol Assess Statement 1994; December 12–14.
   Google Scholar
• Jackson AS, Pollock ML, Graves JE, Mahar MT. Reliability and validity of bioelectrical impedance in determining body composition. J Appl Physiol 1988; 64: 529–34
   PubMed Web of Science ®Google Scholar
• Bedogni G, Malavolti M, Severi S, Poli M, Mussi C, Fantuzzi AL, et al. Accuracy of an eight-point tactile-electrode impedance method in the assessment of total body water. Eur J Clin Nutr. 2002; 56: 1143–8
   PubMed Web of Science ®Google Scholar
• Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Saverymuttu SH, Joseph AEA, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986; 292: 13–5
   PubMed Web of Science ®Google Scholar
• Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745–50
   PubMed Web of Science ®Google Scholar
• Sanyal AJ. Nonalcoholic steatohepatitis. Clin Perspect Gastroenterol 2000; 3: 129–39
   Google Scholar
• Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103–9
   PubMed Web of Science ®Google Scholar
• van Hoek B. Non-alcoholic fatty liver disease: a brief review. Scand J Gastroenterol 2004; Suppl 241: 56–9
   Google Scholar
• Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with non-alcoholic steatohepatitis. Hepatology 1999; 30: 1356–62
   PubMed Web of Science ®Google Scholar
• Hultcrantz R, Gabrielsson N. Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 1993; 233: 7–12
   PubMedGoogle Scholar
• Ludwig J, Viggiano TR, McGill DB, Oh BJ. Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434–8
   PubMed Web of Science ®Google Scholar
• Diehl AM, Goodman Z, Ishak KG. Alcohol-like liver disease in non-alcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056–62
   PubMed Web of Science ®Google Scholar
• Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74–80
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL, Jawaid Q, Tortorelli K, LeClair P, Cobb J, Lambrecht RW, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999; 31: 421–9
   PubMed Web of Science ®Google Scholar
• Teli MR, James OF, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995; 22: 1714–9
   PubMed Web of Science ®Google Scholar
• Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology 1992; 15: 567–71
   PubMed Web of Science ®Google Scholar
• Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Ishibashi K, Matsuura Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997; 78: 1527–31
   PubMed Web of Science ®Google Scholar
• Lee RG. Non-alcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989; 20: 594–8
   PubMed Web of Science ®Google Scholar
• Kral JG, Schaffner F, Pierson RN, Wang J. Body fat topography as an independent prediction of fatty liver. Metabolism 1993; 42: 548–51
   PubMed Web of Science ®Google Scholar
• Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Lie YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413–9
   PubMed Web of Science ®Google Scholar
• Vajro P, Fontanella A, Perna C, Orso G, Tedesco M, De Vinsenzo A. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J Pediatr 1994; 125: 239–41
   PubMedGoogle Scholar
• Eriksson S, Eriksson KF, Bondesson L. Non-alcoholic steatohepatitis in obesity: reversible condition. Acta Med Scand 1986; 220: 83–8
   PubMed Web of Science ®Google Scholar